HUT52500A - Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components - Google Patents

Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components

Info

Publication number
HUT52500A
HUT52500A HU875686A HU568787A HUT52500A HU T52500 A HUT52500 A HU T52500A HU 875686 A HU875686 A HU 875686A HU 568787 A HU568787 A HU 568787A HU T52500 A HUT52500 A HU T52500A
Authority
HU
Hungary
Prior art keywords
naphtiridine
terc
quinoline
substituted
alkyl
Prior art date
Application number
HU875686A
Other languages
Hungarian (hu)
Inventor
Abraham Weber
Daniel Bouzard
Munir Essiz
Cesare Pierre Di
Jacquet
Phillippe Remuzon
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HUT52500A publication Critical patent/HUT52500A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
HU875686A 1986-10-08 1987-10-08 Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components HUT52500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91675286A 1986-10-08 1986-10-08

Publications (1)

Publication Number Publication Date
HUT52500A true HUT52500A (en) 1990-07-28

Family

ID=25437769

Family Applications (3)

Application Number Title Priority Date Filing Date
HU875686A HUT52500A (en) 1986-10-08 1987-10-08 Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components
HU875686A HU203753B (en) 1986-10-08 1987-10-08 Process for producing 1-terc-alkyl-substituted naphtiridine and quinoline-carboxylic acids and pharmaceutical compositions contianing them
HU911136A HU911136D0 (en) 1986-10-08 1987-10-08 Process for producing 1-tertiary-alkyl-substituted naphtyridine- and quinoline-carbonic acid derivatives and intermediate products

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU875686A HU203753B (en) 1986-10-08 1987-10-08 Process for producing 1-terc-alkyl-substituted naphtiridine and quinoline-carboxylic acids and pharmaceutical compositions contianing them
HU911136A HU911136D0 (en) 1986-10-08 1987-10-08 Process for producing 1-tertiary-alkyl-substituted naphtyridine- and quinoline-carbonic acid derivatives and intermediate products

Country Status (8)

Country Link
EP (1) EP0288519A4 (en)
AU (2) AU611400B2 (en)
DD (2) DD266354A5 (en)
EG (1) EG18484A (en)
FI (1) FI883894A0 (en)
HU (3) HUT52500A (en)
WO (1) WO1988002627A1 (en)
ZA (1) ZA877471B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62108878A (en) * 1985-11-05 1987-05-20 Kyorin Pharmaceut Co Ltd Quinolonecarboxylic acid derivative and production thereof
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US4916141A (en) * 1989-03-28 1990-04-10 Warner-Lambert Company (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
AU618460B2 (en) * 1989-04-18 1991-12-19 Hokuriku Pharmaceutical Co. Ltd. Thiazetoquinoline-3-carboxylic acid derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
TW425394B (en) * 1996-04-24 2001-03-11 Daiichi Seiyaku Co Antimicrobial quinolone derivatives having 3-(N-cycloalkyl) aminomethylpyrrolidine group
US6872742B2 (en) 1996-08-28 2005-03-29 The Procter & Gamble Company Substituted cyclic amine metalloprotease inhibitors
PL331802A1 (en) 1996-08-28 1999-08-02 Procter & Gamble Substituted cyclic amines as metaloprotease inhibitors
BR9810841A (en) 1997-07-31 2001-07-10 Procter & Gamble Alicyclic metalloprotease inhibitors
US6197770B1 (en) 1999-03-03 2001-03-06 The Procter & Gamble Co. Alkenyl- and alkynl-containing metalloprotease inhibitors
SE0003795D0 (en) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
BR0314201A (en) 2002-09-10 2005-07-12 Pfizer Prod Inc Diazabicyclic Compounds Useful in the Treatment of CNS Diseases and Other Disorders
US7648980B2 (en) * 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH408036A (en) * 1960-02-17 1966-02-28 Lepetit Spa Process for the preparation of 3,8-diazabicyclo- (3,2,1) -octane-2,4-dione
GB937183A (en) * 1960-02-17 1963-09-18 Lepetit Spa 3,8-diazabicyclo-[3,2,1]-octanes
DE2808070A1 (en) * 1978-02-24 1979-08-30 Bayer Ag PROCESS FOR THE PRODUCTION OF 4-PYRIDONE-3-CARBONIC ACIDS AND / OR DERIVATIVES
GB2093018B (en) * 1979-08-22 1984-09-12 Kyorin Seiyaku Kk 6,8-difluoro-quinoline carboxylic acid derivatives
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
DE3509546A1 (en) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-AMINO-1- (SUBST.CYCLOPROPYL) -1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4772706A (en) * 1986-01-13 1988-09-20 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
DE3601567A1 (en) * 1986-01-21 1987-07-23 Bayer Ag 7- (AZABICYCLOALKYL) -CHINOLONCARBONIC ACID AND -NAPHTHYRIDON-CARBONIC ACID DERIVATIVES

Also Published As

Publication number Publication date
HU203753B (en) 1991-09-30
FI883894A (en) 1988-08-23
DD266354A5 (en) 1989-03-29
WO1988002627A1 (en) 1988-04-21
EG18484A (en) 1993-04-30
AU611400B2 (en) 1991-06-13
DD280530A5 (en) 1990-07-11
EP0288519A4 (en) 1992-04-15
EP0288519A1 (en) 1988-11-02
ZA877471B (en) 1988-04-05
HU911136D0 (en) 1991-10-28
FI883894A0 (en) 1988-08-23
AU7632691A (en) 1991-08-08
AU8158187A (en) 1988-05-06

Similar Documents

Publication Publication Date Title
HUT54999A (en) Process for producing imidazolyl-alkenic acids and pharmaceutical compositions containing them as active components
HUT46710A (en) Process for producing peptode derivatives and pharmaceutical compositions containing them as active components
HUT47274A (en) Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components
HUT46699A (en) Process for producing phosphinic acid derivatives and pharmaceutical compositions containing them as active components
HU199453B (en) Process for producing quinoloncarboxylic acid derivatives and pharmaceutical compositions comprising same
HUT45252A (en) Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
HUT47131A (en) Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient
HUT48247A (en) Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components
HUT51279A (en) Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
PT85886A (en) Process for producing 1-tertiary-alkyl-substituted naphthrydine-carboxylic and quinoline-carboxylic acids and pharmaceutic compositions containing them and starting compounds
HUT48246A (en) Process for producing n-substituted benzamides and pharmaceutical compositions containing them as active components
HU200177B (en) Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
HUT52500A (en) Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components
HUT47865A (en) Process for producing pharmaceutical compositions containing somatostatin as active component
HUT49494A (en) Process for producing active component of pharmaceutical compositions
HUT46645A (en) Process for producing alpha-halogen-dicarboxylic acids and their derivatives and pharmaceutical compositions comprising the same
HUT54671A (en) Process for producing benzothiopirane derivatives and pharmaceutical compositions containing them as active component
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT45540A (en) Process for producing beta-lactame compounds and pharmaceutical compositions containing them as active componenets
HUT48251A (en) Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components
HUT46930A (en) Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components
HUT50112A (en) Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component
HUT49598A (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient